• Wed, December 19, 2018
  • Wed, December 26, 2018
  • Thu, December 27, 2018
  • Fri, December 21, 2018
  • Thu, December 20, 2018

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $401 on, Dec 19th, 2018

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $394 to $401 on, Dec 19th, 2018.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 19th, 2018


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $436 on, Wednesday, October 24th, 2018
  • Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $400 on, Monday, October 1st, 2018